K. Loucif, Hassiba Benabdallah, Fatima Benchikh, C. Bensouici, Smain Amira
{"title":"柽柳水提液和甲醇提液抗氧化和抗胆碱酯酶作用的体外研究","authors":"K. Loucif, Hassiba Benabdallah, Fatima Benchikh, C. Bensouici, Smain Amira","doi":"10.2174/1573408017666220713100342","DOIUrl":null,"url":null,"abstract":"\n\nOxidative stress plays a critical role in the pathological process of Alzheimer’s disease (AD). There is a growing interest in natural anti-oxidants and cholinesterase inhibitors from medicinal plants that may aid in the prevention against oxidative injury and in the treatment of AD. Athamanta sicula L. is an important medicinal plant.\n\n\n\nThe aim of current study was to investigate the total phenolic content, antioxidant and anti-cholinesterase properties of aqueous (AqE) and methanolic extracts (MethE) from Athamanta sicula L. (A. sicula L.).\n\n\n\nThe phenanthroline, ABTS free radical scavenging, β-carotene bleaching methods were utilized to assess the antioxidant capacity. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory methods were used to determine the anti-cholinesterase effect.\n\n\n\nThese extracts were rich in phenolic contents. It was capable of scavenging free radicals, inhibiting lipid peroxidation, and reducing agents. A. sicula L. had a remarkable cholinesterase inhibitory effect.\n\n\n\nThese results support that A. sicula L. could be a new source of anti-oxidant and anti-cholinesterase natural drugs. Further studies on the isolation and characterization of active principles of anti-oxidant and tyrosinase inhibitory activities are needed.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"In vitro examination of antioxidant and anti-cholinesterase effects of Athamanta sicula L. aqueous and methanolic extracts\",\"authors\":\"K. Loucif, Hassiba Benabdallah, Fatima Benchikh, C. Bensouici, Smain Amira\",\"doi\":\"10.2174/1573408017666220713100342\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nOxidative stress plays a critical role in the pathological process of Alzheimer’s disease (AD). There is a growing interest in natural anti-oxidants and cholinesterase inhibitors from medicinal plants that may aid in the prevention against oxidative injury and in the treatment of AD. Athamanta sicula L. is an important medicinal plant.\\n\\n\\n\\nThe aim of current study was to investigate the total phenolic content, antioxidant and anti-cholinesterase properties of aqueous (AqE) and methanolic extracts (MethE) from Athamanta sicula L. (A. sicula L.).\\n\\n\\n\\nThe phenanthroline, ABTS free radical scavenging, β-carotene bleaching methods were utilized to assess the antioxidant capacity. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory methods were used to determine the anti-cholinesterase effect.\\n\\n\\n\\nThese extracts were rich in phenolic contents. It was capable of scavenging free radicals, inhibiting lipid peroxidation, and reducing agents. A. sicula L. had a remarkable cholinesterase inhibitory effect.\\n\\n\\n\\nThese results support that A. sicula L. could be a new source of anti-oxidant and anti-cholinesterase natural drugs. Further studies on the isolation and characterization of active principles of anti-oxidant and tyrosinase inhibitory activities are needed.\\n\",\"PeriodicalId\":35405,\"journal\":{\"name\":\"Current Enzyme Inhibition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Enzyme Inhibition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573408017666220713100342\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408017666220713100342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
In vitro examination of antioxidant and anti-cholinesterase effects of Athamanta sicula L. aqueous and methanolic extracts
Oxidative stress plays a critical role in the pathological process of Alzheimer’s disease (AD). There is a growing interest in natural anti-oxidants and cholinesterase inhibitors from medicinal plants that may aid in the prevention against oxidative injury and in the treatment of AD. Athamanta sicula L. is an important medicinal plant.
The aim of current study was to investigate the total phenolic content, antioxidant and anti-cholinesterase properties of aqueous (AqE) and methanolic extracts (MethE) from Athamanta sicula L. (A. sicula L.).
The phenanthroline, ABTS free radical scavenging, β-carotene bleaching methods were utilized to assess the antioxidant capacity. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory methods were used to determine the anti-cholinesterase effect.
These extracts were rich in phenolic contents. It was capable of scavenging free radicals, inhibiting lipid peroxidation, and reducing agents. A. sicula L. had a remarkable cholinesterase inhibitory effect.
These results support that A. sicula L. could be a new source of anti-oxidant and anti-cholinesterase natural drugs. Further studies on the isolation and characterization of active principles of anti-oxidant and tyrosinase inhibitory activities are needed.
期刊介绍:
Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.